Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.



This is a "connection" page, showing publications co-authored by Tatiana Kutateladze and Kendra Vann.

Connection Strength
  1. Vann KR, Pal D, Smith AL, Sahar NE, Krishnaiah M, El-Gamal D, Kutateladze TG. Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma. Mol Biomed. 2022 Jan 15; 3(1):2.
    View in: PubMed
    Score: 0.999
  2. Vann KR, Vishweshwaraiah YL, Dokholyan NV, Kutateladze TG. Searching for methyllysine-binding aromatic cages. Biochem J. 2021 10 15; 478(19):3613-3619.
    View in: PubMed
    Score: 0.982
  3. Vann KR, Klein BJ, Kutateladze TG. Mechanistic similarities in recognition of histone tails and DNA by epigenetic readers. Curr Opin Struct Biol. 2021 12; 71:1-6.
    View in: PubMed
    Score: 0.953
  4. Vann KR, Tencer AH, Kutateladze TG. Inhibition of translation and immune responses by the virulence factor Nsp1 of SARS-CoV-2. Signal Transduct Target Ther. 2020 10 09; 5(1):234.
    View in: PubMed
    Score: 0.915
  5. Vann KR, Pal D, Morales GA, Burgoyne AM, Durden DL, Kutateladze TG. Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets. Sci Rep. 2020 07 21; 10(1):12027.
    View in: PubMed
    Score: 0.901
  6. Vann KR, Kutateladze TG. Architecture of PRC2 Holo Complexes. Trends Biochem Sci. 2018 07; 43(7):487-489.
    View in: PubMed
    Score: 0.773
  7. Vann KR, Kutateladze TG. Histone H3 Dual Ubiquitylation Mediates Maintenance DNA Methylation. Mol Cell. 2017 10 19; 68(2):261-262.
    View in: PubMed
    Score: 0.744
  8. Liu J, Xue Z, Vann KR, Shi X, Kutateladze TG. Protocol for Biochemical Analysis and Structure Determination of the ZZ Domain of the E3 Ubiquitin Ligase HERC2. STAR Protoc. 2020 Dec 18; 1(3):100155.
    View in: PubMed
    Score: 0.230
  9. Liu J, Xue Z, Zhang Y, Vann KR, Shi X, Kutateladze TG. Structural Insight into Binding of the ZZ Domain of HERC2 to Histone H3 and SUMO1. Structure. 2020 11 03; 28(11):1225-1230.e3.
    View in: PubMed
    Score: 0.226
  10. Zhang Y, Guo Y, Gough SM, Zhang J, Vann KR, Li K, Cai L, Shi X, Aplan PD, Wang GG, Kutateladze TG. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion. Nat Commun. 2020 07 03; 11(1):3339.
    View in: PubMed
    Score: 0.224
  11. Zhang Y, Ahn J, Green KJ, Vann KR, Black J, Brooke CB, Kutateladze TG. MORC3 Is a Target of the Influenza A Viral Protein NS1. Structure. 2019 06 04; 27(6):1029-1033.e3.
    View in: PubMed
    Score: 0.206
  12. Klein BJ, Vann KR, Andrews FH, Wang WW, Zhang J, Zhang Y, Beloglazkina AA, Mi W, Li Y, Li H, Shi X, Kutateladze AG, Strahl BD, Liu WR, Kutateladze TG. Structural insights into the p-p-p stacking mechanism and DNA-binding activity of the YEATS domain. Nat Commun. 2018 11 01; 9(1):4574.
    View in: PubMed
    Score: 0.200
  13. Klein BJ, Ahmad S, Vann KR, Andrews FH, Mayo ZA, Bourriquen G, Bridgers JB, Zhang J, Strahl BD, Côté J, Kutateladze TG. Yaf9 subunit of the NuA4 and SWR1 complexes targets histone H3K27ac through its YEATS domain. Nucleic Acids Res. 2018 01 09; 46(1):421-430.
    View in: PubMed
    Score: 0.189
  14. van Wely KH, Mora Gallardo C, Vann KR, Kutateladze TG. Epigenetic countermarks in mitotic chromosome condensation. Nucleus. 2017 Mar 04; 8(2):144-149.
    View in: PubMed
    Score: 0.176
  15. Pal D, Vann KR, Joshi S, Sahar NE, Morales GA, El-Gamal D, Kutateladze TG, Durden DL. The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma. iScience. 2021 Sep 24; 24(9):102931.
    View in: PubMed
    Score: 0.060
  16. Acharya A, Pandey K, Thurman M, Challagundala KB, Vann KR, Kutateladze TG, Morales GA, Durden DL, Byrareddy SN. Blockade of SARS-CoV-2 infection in vitro by highly potent PI3K-a/mTOR/BRD4 inhibitor. bioRxiv. 2021 Mar 05.
    View in: PubMed
    Score: 0.059
  17. Burgoyne AM, Vann KR, Joshi S, Morales GA, Vega FM, Singh A, Pal D, Merati AB, Kutateladze TG, Durden DL. A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity. Cell Discov. 2020; 6:49.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)